| Candesartan |
20110677 |
Repido, Tablet, 16, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arzneimittel AG Germany; Stada Arzneimittel GmbH Austria; Centrafarm Services Holland |
8.88 |
1.78 |
10.66 |
7% |
0.62 |
9.5 |
1.9 |
11.4 |
20% |
1.78 |
11.28 |
2.26 |
13.54 |
|
НСР-2506/24.01.2014 |
14.02.2014 |
14.02.2014 |
Неактивен |
3854 |
| Candesartan |
20110677 |
Repido, Tablet, 16, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arzneimittel AG Germany; Stada Arzneimittel GmbH Austria; Centrafarm Services Holland |
12.48 |
2.5 |
14.98 |
6% |
0.75 |
13.23 |
2.65 |
15.88 |
18% |
2.25 |
15.48 |
3.1 |
18.58 |
|
КЦРР-1357/05.09.2012 |
02.10.2012 |
02.10.2012 |
Неактивен |
3854 |
| Candesartan |
20110676 |
Repido, Tablet, 8, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Arzneimittel AG Germany; Stada Arzneimittel GmbH Austria; Centrafarm Services Holland |
11.05 |
2.21 |
13.26 |
6% |
0.66 |
11.71 |
2.34 |
14.05 |
18% |
1.99 |
13.7 |
2.74 |
16.44 |
|
КЦРР-1226/13.08.2012 |
14.09.2012 |
14.09.2012 |
Неактивен |
2481 |
| Candesartan, Hydrochlortiazide |
20120512 |
Repido plus, Tablet, 8 mg/12,5 mg, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Delorbis Pharmaceuticals Ltd, Кипър; HBM Pharma s.r.o.,Словакия;Pharmaceutical Works Polpharma, Полша;Stada Arzneimittel AG, Германия; Iberfar-Indusria Farmaceutica S.A., Португалия |
6.45 |
1.29 |
7.74 |
7% |
0.45 |
6.9 |
1.38 |
8.28 |
20% |
1.29 |
8.19 |
1.64 |
9.83 |
НСР-8058/12.02.2016.; промяна в обстоятелства НСр-8635/31.03.2016. |
КЦРР-2362/21.02.2013.; НСР-12732/19.05.2017 г. |
03.06.2017 |
02.07.2017 |
Активен |
1674 |
| Candesartan, Hydrochlortiazide |
20120512 |
Repido plus, Tablet, 8 mg/ 12,5 mg, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Delorbis Pharmaceuticals Ltd, Кипър; HBM Pharma s.r.o.,Словакия;Pharmaceutical Works Polpharma, Полша;Stada Arzneimittel AG, Германия; Iberfar-Indusria Farmaceutica S.A., Португалия |
7.24 |
1.45 |
8.69 |
7% |
0.51 |
7.75 |
1.55 |
9.3 |
20% |
1.45 |
9.2 |
1.84 |
11.04 |
НСР-8058/12.02.2016.; промяна в обстоятелства НСр-8635/31.03.2016. |
КЦРР-2362/21.02.2013. |
14.03.2013 |
14.03.2013 |
Неактивен |
1674 |
| Candesartan, Hydrochlortiazide |
20120513 |
Repido plus, Tablet, 16 mg/12,5 mg, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Delorbis Pharmaceuticals Ltd, Кипър; HBM Pharma s.r.o.,Словакия;Pharmaceutical Works Polpharma, Полша;Stada Arzneimittel AG, Германия; Iberfar-Indusria Farmaceutica S.A., Португалия |
6.45 |
1.29 |
7.74 |
7% |
0.45 |
6.9 |
1.38 |
8.28 |
20% |
1.29 |
8.19 |
1.64 |
9.83 |
НСР-8058/12.02.2016.; промяна в обстоятелства НСР-8636/31.03.2016. |
КЦРР-2362/21.02.2013.; НСР-12734/19.05.2017 г |
03.06.2017 |
02.07.2017 |
Активен |
1675 |
| Candesartan, Hydrochlortiazide |
20120513 |
Repido plus, Tablet, 16 mg/12,5 mg, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Delorbis Pharmaceuticals Ltd, Кипър; HBM Pharma s.r.o.,Словакия;Pharmaceutical Works Polpharma, Полша;Stada Arzneimittel AG, Германия; Iberfar-Indusria Farmaceutica S.A., Португалия |
8.21 |
1.64 |
9.85 |
7% |
0.57 |
8.78 |
1.76 |
10.54 |
20% |
1.64 |
10.42 |
2.08 |
12.5 |
НСР-8058/12.02.2016.; промяна в обстоятелства НСР-8636/31.03.2016. |
КЦРР-2362/21.02.2013. |
14.03.2013 |
14.03.2013 |
Неактивен |
1675 |
| Candesartan, Hydrochlortiazide |
20120514 |
Repido plus, Tablet, 32 mg/12.5 mg, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Delorbis Pharmaceuticals Ltd, Кипър; HBM Pharma s.r.o.,Словакия;Pharmaceutical Works Polpharma, Полша;Stada Arzneimittel AG, Германия; Iberfar-Indusria Farmaceutica S.A., Португалия |
10.17 |
2.03 |
12.2 |
6% |
0.61 |
10.78 |
2.16 |
12.94 |
18% |
1.83 |
12.61 |
2.52 |
15.13 |
НСР-8058/12.02.2016.; промяна в обстоятелства НСР-8637/31.03.2016. |
КЦРР-2362/21.02.2013. |
14.03.2013 |
14.03.2013 |
Активен |
1676 |
| Levetiracetam |
20120114 |
Repitend, Film coated tablet, 1000, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
22.96 |
4.59 |
27.55 |
6% |
1.38 |
24.34 |
4.87 |
29.21 |
18% |
4.13 |
28.47 |
5.69 |
34.16 |
корекционно решение НСР-9803/14.07.2016 |
НСР-8017/08.02.2016.; НСР-12587/05.05.2017 |
24.02.2016 |
02.06.2017 |
Заличен |
1414 |
| Levetiracetam |
20120114 |
Repitend, Film coated tablet, 1000, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
22.96 |
4.59 |
27.55 |
6% |
1.38 |
24.34 |
4.87 |
29.21 |
18% |
4.13 |
28.47 |
5.69 |
34.16 |
корекционно решение НСР-9803/14.07.2016 |
НСР-8017/08.02.2016. |
24.02.2016 |
02.08.2016 |
Неактивен |
1414 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 250, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
5.74 |
1.15 |
6.89 |
7% |
0.4 |
6.14 |
1.23 |
7.37 |
20% |
1.15 |
7.29 |
1.46 |
8.75 |
|
НСР-8019/08.02.2016.; НСР-12588/05.05.2017 |
24.02.2016 |
02.06.2017 |
Заличен |
1412 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 250, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
5.74 |
1.15 |
6.89 |
7% |
0.4 |
6.14 |
1.23 |
7.37 |
20% |
1.15 |
7.29 |
1.46 |
8.75 |
|
НСР-8019/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
1412 |
| Levetiracetam |
20120112 |
Repitend, Film coated tablet, 500, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
11.48 |
2.3 |
13.78 |
6% |
0.69 |
12.17 |
2.43 |
14.6 |
18% |
2.07 |
14.24 |
2.85 |
17.09 |
корекционно решение НСР-9803/14.07.2016 |
НСР-8018/08.02.2016. |
24.02.2016 |
02.08.2016 |
Активен |
1413 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 500, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
11.48 |
2.3 |
13.78 |
6% |
0.69 |
12.17 |
2.43 |
14.6 |
18% |
2.07 |
14.24 |
2.85 |
17.09 |
|
НСР-8018/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
1413 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 1000, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
22.96 |
4.59 |
27.55 |
6% |
1.38 |
24.34 |
4.87 |
29.21 |
18% |
4.13 |
28.47 |
5.69 |
34.16 |
|
НСР-8017/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
1414 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 1000, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
59.18 |
11.84 |
71.02 |
4% |
2.37 |
61.55 |
12.31 |
73.86 |
16% |
9.47 |
71.02 |
14.2 |
85.22 |
|
КЦРР-1518/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1414 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 250, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
20.81 |
4.16 |
24.97 |
6% |
1.25 |
22.06 |
4.41 |
26.47 |
18% |
3.75 |
25.81 |
5.16 |
30.97 |
|
КЦРР-1518/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1412 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 500, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
41.58 |
8.32 |
49.9 |
4% |
1.66 |
43.24 |
8.65 |
51.89 |
16% |
6.65 |
49.89 |
9.98 |
59.87 |
|
КЦРР-1518/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1413 |
| Levetiracetam |
20120115 |
Repitend, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Medana Pharma S.A., Poland |
57.21 |
11.44 |
68.65 |
4% |
2.29 |
59.5 |
11.9 |
71.4 |
16% |
9.15 |
68.65 |
13.73 |
82.38 |
корекц. Решение НСР-9826/21.07.2016 |
КЦРР-1517/18.10.2012 |
02.11.2012 |
02.09.2016 |
Активен |
1411 |
| Levetiracetam |
20120111 |
Repitend, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Medana Pharma S.A., Poland |
57.21 |
11.44 |
68.65 |
4% |
2.29 |
59.5 |
11.9 |
71.4 |
16% |
9.15 |
68.65 |
13.73 |
82.38 |
|
КЦРР-1517/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1411 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
10212.8 |
2042.56 |
12255.36 |
4% |
10 |
10222.8 |
2044.56 |
12267.36 |
16% |
25 |
10247.8 |
2049.56 |
12297.36 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014; НСР-13264/20.07.2017 |
04.08.2017 |
02.09.2017 |
Активен |
3416 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
10212.8 |
2042.56 |
12255.36 |
4% |
10 |
10222.8 |
2044.56 |
12267.36 |
16% |
25 |
10247.8 |
2049.56 |
12297.36 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014; НСР-13264/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
3416 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
14343.41 |
2868.68 |
17212.09 |
4% |
10 |
14353.41 |
2870.68 |
17224.09 |
16% |
25 |
14378.41 |
2875.68 |
17254.09 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014 |
16.12.2014 |
16.12.2014 |
Неактивен |
3416 |
| Goserelin |
20150379 |
Reseligo, implant in pre-filled syringe, 3.6, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
64.91 |
12.98 |
77.89 |
4% |
2.6 |
67.51 |
13.5 |
81.01 |
16% |
10.39 |
77.9 |
15.58 |
93.48 |
|
НСР-8086/12.02.2016.; НСР-10904/11.11.2016 (допуска предварително изпълнение) |
11.11.2016 |
02.12.2016 |
Активен |
4188 |
| Goserelin |
20150379 |
Reseligo, implant in pre-filled syringe, 3.6, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
90.03 |
18.01 |
108.04 |
4% |
3.6 |
93.63 |
18.73 |
112.36 |
16% |
14.4 |
108.03 |
21.61 |
129.64 |
|
НСР-8086/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
4188 |